About: Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries Goto Sponge Distinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
rdfs:seeAlso	http://dx.doi.org/10.1136/ard.2010.148759
Description	Analyses of efficacy of rituximab in real clinical practice of European registries. Pooled data of 1 year treatment in 10 countries.Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed Analyses of efficacy of rituximab in real clinical practice of European registries. Pooled data of 1 year treatment in 10 countries.Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed (en)
Title	Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries (en)
skos:prefLabel	Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries (en)
skos:notation	RIV/00216208:11110/11:9931!RIV12-MSM-11110___
http://linked.open...avai/predkladatel	1. lékařská fakulta
http://linked.open...avai/riv/aktivita	V
http://linked.open...avai/riv/aktivity	V
http://linked.open...iv/cisloPeriodika	9
http://linked.open...vai/riv/dodaniDat	2012
http://linked.open...aciTvurceVysledku	Pavelka, Karel
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Univerzita Karlova v Praze / 1. lékařská fakulta
http://linked.open...dnocenehoVysledku	202059
http://linked.open...ai/riv/idVysledku	RIV/00216208:11110/11:9931
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; INADEQUATE RESPONSE; B-CELLS; EFFICACY; AGENTS; METHOTREXATE; THERAPY; MULTICENTER; INHIBITION (en)
http://linked.open.../riv/klicoveSlovo	INHIBITION AGENTS B-CELLS DOUBLE-BLIND EFFICACY INADEQUATE RESPONSE METHOTREXATE MULTICENTER PLACEBO-CONTROLLED TRIAL THERAPY
http://linked.open...odStatuVydavatele	GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV	[B4A2FBBC3CA7]
http://linked.open...i/riv/nazevZdroje	Annals of the Rheumatic Diesases
http://linked.open...in/vavai/riv/obor	FE
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...cetTvurcuVysledku	14 (xsd:int)
http://linked.open...UplatneniVysledku	2011
http://linked.open...v/svazekPeriodika	70
http://linked.open...iv/tvurceVysledku	Pavelka, Karel (Gomez-Reino, J. Chatzidionysiou, Katerin Gabay, Cem Hetland, Merete Lund Kvien, Tore K. Lie, Elisabeth Lukina, Galina Nasonov, Evgeny Nordstrom, Dan C. Tarp, Ulrik Tomsic, M. Van Vollenhoven, R. F. van Riel, Piet L. C. M.
http://linked.open...ain/vavai/riv/wos	000293275600010
issn	0003-4967
number of pages	6 (xsd:int)
http://localhost/t...ganizacniJednotka	11110
is http://linked.open...avai/riv/vysledek of	Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 30 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software